Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 9 (September)

1. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
   Br J Cancer, 93(5): 590-6. [Abstract] [Full-text]
2. Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC).
   Br J Cancer, 93(5): 582-9. [Abstract] [Full-text]
3. The effect of spiritual healing on in vitro tumour cell proliferation and viability--an experimental study.
   Br J Cancer, 93(5): 538-43. [Abstract] [Full-text]
4. Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy.
   Br J Cancer, 93(5): 520-8. [Abstract] [Full-text]
5. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
   Mol Cell Biol, 25(18): 7953-65. [Abstract] [Full-text]
6. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: Immunologic effects.
   J Clin Oncol, 23(25): 6097-106. [Abstract] [Full-text]
7. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects.
   J Clin Oncol, 23(25): 6083-96. [Abstract] [Full-text]
8. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer?
   J Clin Oncol, 23(25): 6037-42. [Abstract] [Full-text]
9. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
   J Clin Oncol, 23(25): 6027-36. [Abstract] [Full-text]
10. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.
    J Clin Oncol, 23(25): 6019-26. [Abstract] [Full-text]
11. Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients.
    J Clin Oncol, 23(25): 6009-18. [Abstract] [Full-text]
12. Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.
    J Clin Oncol, 23(25): 6002-8. [Abstract] [Full-text]
13. Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
    J Clin Oncol, 23(25): 5993-6001. [Abstract] [Full-text]
14. Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease.
    Br J Cancer, 93(5): 552-6. [Abstract] [Full-text]
15. Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer.
    Br J Cancer, 93(5): 515-9. [Abstract] [Full-text]
16. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
    J Clin Oncol, 23(25): 5973-82. [Abstract] [Full-text]
17. Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer.
    J Clin Oncol, 23(25): 6117-25. [Abstract] [Full-text]
18. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
    J Clin Oncol, 23(25): 5960-72. [Abstract] [Full-text]
19. Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.
    J Clin Oncol, 23(25): 5983-92. [Abstract] [Full-text]
20. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
    Lancet, 366(9488): 818-24. [Abstract] [Full-text]
21. Optical coherence tomography characteristics of choroidal metastasis.
    Ophthalmology, 112(9): 1612-9. [Abstract] [Full-text]
22. Gemcitabine plus paclitaxel in breast cancer.
    Semin Oncol, 32(4): S14-21. [Abstract] [Full-text]
23. Patient delay in women presenting with advanced breast cancer: an Iranian study.
    Public Health, 119(10): 885-91. [Abstract] [Full-text]
24. Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.
    Genes Chromosomes Cancer, 44(3): 233-46. [Abstract] [Full-text]
25. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.
    J Natl Cancer Inst, 97(17): 1302-6. [Abstract] [Full-text]
26. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
    J Natl Cancer Inst, 97(17): 1262-71. [Abstract] [Full-text]
27. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    J Natl Cancer Inst, 97(17): 1254-61. [Abstract] [Full-text]
28. A case of esophageal stricture due to metastatic breast cancer diagnosed by endoscopic mucosal resection.
    Jpn J Clin Oncol, 35(8): 483-6. [Abstract] [Full-text]
29. Self reported stress and risk of breast cancer: prospective cohort study.
    BMJ, 331(7516): 548. [Abstract] [Full-text]
30. In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin.
    Biochim Biophys Acta, 1725(2): 145-51. [Abstract] [Full-text]
31. AKT activation predicts outcome in breast cancer patients treated with tamoxifen.
    J Pathol, 207(2): 139-46. [Abstract] [Full-text]
32. Differences in screening mammography outcomes among White, Chinese, and Filipino women.
    Arch Intern Med, 165(16): 1862-8. [Abstract] [Full-text]
33. Some current issues in breast cancer screening.
    J Med Screen, 12(3): 128-33. [Abstract] [Full-text]
34. The role of arbitration of discordant reports at double reading of screening mammograms.
    J Med Screen, 12(3): 125-7. [Abstract] [Full-text]
35. Breast cancer cell-targeted oxidative stress: enhancement of cancer cell uptake of conjugated linoleic acid, activation of p53, and inhibition of proliferation.
    Exp Mol Pathol, 79(2): 118-25. [Abstract] [Full-text]
36. Interim results from the FibroAdenoma Cryoablation Treatment Registry.
    Am J Surg, 190(4): 647-51; discussion 651-2. [Abstract] [Full-text]
37. Laparoscopic-assisted axillary dissection in breast cancer surgery.
    Am J Surg, 190(4): 641-3. [Abstract] [Full-text]
38. Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?
    Am J Surg, 190(4): 633-40. [Abstract] [Full-text]
39. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
    Am J Surg, 190(4): 628-32. [Abstract] [Full-text]
40. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast.
    Am J Surg, 190(4): 623-7. [Abstract] [Full-text]
41. Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery.
    Am J Surg, 190(4): 614-7. [Abstract] [Full-text]
42. Therapeutic options for occult breast cancer: a survey of the American Society of Breast Surgeons and review of the literature.
    Am J Surg, 190(4): 609-13. [Abstract] [Full-text]
43. Understanding the mechanisms creating false positive lumpectomy margins.
    Am J Surg, 190(4): 606-8. [Abstract] [Full-text]
44. Determinants of mastectomy in breast conservation therapy candidates.
    Am J Surg, 190(4): 602-5. [Abstract] [Full-text]
45. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Am J Surg, 190(4): 598-601. [Abstract] [Full-text]
46. Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients.
    Am J Surg, 190(4): 595-7. [Abstract] [Full-text]
47. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.
    Am J Surg, 190(4): 588-91. [Abstract] [Full-text]
48. Cohort study of women at risk for breast cancer and gross cystic disease.
    Am J Surg, 190(4): 583-7. [Abstract] [Full-text]
49. Tissue compression is not necessary for needle-localized lesion identification.
    Am J Surg, 190(4): 580-2. [Abstract] [Full-text]
50. Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer.
    Am J Surg, 190(4): 576-9. [Abstract] [Full-text]
51. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.
    Am J Surg, 190(4): 572-5. [Abstract] [Full-text]
52. Correlation of lymphoscintigraphy with the number of sentinel lymph nodes identified intraoperatively in patients with breast cancer.
    Am J Surg, 190(4): 567-9. [Abstract] [Full-text]
53. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
    Am J Surg, 190(4): 563-6. [Abstract] [Full-text]
54. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer.
    Am J Surg, 190(4): 557-62. [Abstract] [Full-text]
55. Biopsy type does not influence sentinel lymph node status.
    Am J Surg, 190(4): 551-6. [Abstract] [Full-text]
56. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram.
    Am J Surg, 190(4): 543-50. [Abstract] [Full-text]
57. Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer.
    Am J Surg, 190(4): 539-42. [Abstract] [Full-text]
58. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial.
    Am J Surg, 190(4): 530-8. [Abstract] [Full-text]
59. The Gail model predicts breast cancer in women with suspicious radiographic lesions.
    Am J Surg, 190(4): 526-9. [Abstract] [Full-text]
60. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
    Am J Surg, 190(4): 521-5. [Abstract] [Full-text]
61. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
    Am J Surg, 190(4): 517-20. [Abstract] [Full-text]
62. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    J Natl Cancer Inst, 97(18): 1382-4. [Abstract] [Full-text]
63. Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor.
    Int J Cancer, 117(4): 561-8. [Abstract] [Full-text]
64. c-MYC Asn11Ser is associated with increased risk for familial breast cancer.
    Int J Cancer, 117(4): 638-42. [Abstract] [Full-text]
65. Lobular breast cancer: excess familiality observed in the Utah Population Database.
    Int J Cancer, 117(4): 655-61. [Abstract] [Full-text]
66. Accumulating evidence on passive and active smoking and breast cancer risk.
    Int J Cancer, 117(4): 619-28. [Abstract] [Full-text]
67. Maternal height, pregnancy estriol and birth weight in reference to breast cancer risk in Boston and Shanghai.
    Int J Cancer, 117(3): 494-8. [Abstract] [Full-text]
68. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway.
    Int J Cancer, 117(3): 340-8. [Abstract] [Full-text]
69. A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.
    Oncology, 69(2): 117-21. [Abstract] [Full-text]
70. The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells.
    Biochem Biophys Res Commun, 336(3): 952-60. [Abstract] [Full-text]
71. Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.
    Lancet, 366(9491): 1108-10. [Abstract] [Full-text]
72. Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction.
    Radiology, 237(1): 57-66. [Abstract] [Full-text]
73. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
    Radiology, 237(1): 45-56. [Abstract] [Full-text]
74. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer.
    Radiology, 237(1): 274-80. [Abstract] [Full-text]
75. Breast lesion detection and classification: comparison of screen-film mammography and full-field digital mammography with soft-copy reading--observer performance study.
    Radiology, 237(1): 37-44. [Abstract] [Full-text]
76. Abdominal carcinomatosis in women with a history of breast cancer.
    Gynecol Oncol, 99(1): 65-70. [Abstract] [Full-text]
77. Work absence after breast cancer diagnosis: a population-based study.
    CMAJ, 173(7): 765-71. [Abstract] [Full-text]
78. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
    J Surg Oncol, 92(1): 23-31. [Abstract] [Full-text]
79. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883.
    J Surg Oncol, 92(1): 32-8. [Abstract] [Full-text]
80. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
    J Surg Oncol, 92(1): 17-22. [Abstract] [Full-text]
81. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial.
    J Surg Oncol, 92(1): 9-15; discussion 15-6. [Abstract] [Full-text]
82. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer.
    J Surg Oncol, 92(1): 4-8. [Abstract] [Full-text]
83. Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women.
    Br J Cancer, 93(7): 817-24. [Abstract] [Full-text]
84. Multicentre validation study of sentinel node biopsy for staging in breast cancer.
    Br J Surg, 92(10): 1221-4. [Abstract] [Full-text]
85. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
    Am J Clin Pathol, 124(3): 342-54. [Abstract] [Full-text]
86. cFos is critical for MCF-7 breast cancer cell growth.
    Oncogene, 24(43): 6516-24. [Abstract] [Full-text]
87. Proliferation marker Ki-67 in early breast cancer.
    J Clin Oncol, 23(28): 7212-20. [Abstract] [Full-text]
88. Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.
    J Clin Oncol, 23(28): 7098-104. [Abstract] [Full-text]
89. Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
    J Clin Oncol, 23(28): 7089-97. [Abstract] [Full-text]
90. Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre.
    J Clin Oncol, 23(28): 7081-8. [Abstract] [Full-text]
91. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients.
    J Clin Oncol, 23(28): 7074-80. [Abstract] [Full-text]
92. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
    J Clin Oncol, 23(28): 6919-30. [Abstract] [Full-text]
93. Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.
    J Clin Oncol, 23(28): 6931-40. [Abstract] [Full-text]
94. Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide.
    J Clin Oncol, 23(28): 6908-18. [Abstract] [Full-text]

© 2004-2010 Breast Cancer Research Today. All Rights Reserved.